Dan Oppenheimer, Group Vice President, Development & Portfolio Strategy – BioMarin Pharmaceutical Inc, presented today at the Wells Fargo research conferences the actual state of art of BioMarin´s drugs under evaluation, including BMN-111. Has said, BioMarin predicts to have results from … Continue reading
June 17, 2014
by inesp.alves
2 Comments